Methodology to Incorporate Biologically Effective Dose and Equivalent Uniform Dose in Patient-Specific 3-Dimensional Dosimetry for Non-Hodgkin Lymphoma Patients Targeted with 131I-Tositumomab Therapy.

Details

Language :

English

ISSN :

01615505

Volume :

51

Issue :

4

Database :

Complementary Index

Journal :

Journal of Nuclear Medicine

Publication Type :

Academic Journal

Accession number :

82601319

Full Text :

https://doi.org/10.2967/jnumed.109.067298